<?xml version="1.0" encoding="UTF-8"?>
<p>Considering the individual contribution to the escape of neutralizing antibodies, we proceeded with the chimeric viruses Bartha-gC
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub> and Bartha-gD
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub> to assess their ability to induce a protective immunity. One-month-old piglets were immunized the piglets with either Bartha-gC
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub>, Bartha-gD
 <sub>
  <italic>HB</italic>
 </sub>
 <sub>1201</sub>, or Bartha-K61 via intramuscular route with a dose of 10
 <sup>5</sup> TCID
 <sub>50</sub>. All piglets survived, had similar daily gain, and did not exhibit any apparent clinical symptom (
 <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S1</xref>), suggesting that these chimeric mutants are avirulent to piglets. We also measured the antibody induction following immunization (
 <xref ref-type="supplementary-material" rid="FS2">Supplementary Figure S2</xref>). The serum samples were collected at weekly internals, and the levels of the gB and gE antibodies were measured by PRV blocking ELISA. The S/N ratio of gB antibodies decreased slightly at 7 dpi. At 14 dpi, the gB-specific antibodies were detected in all immunized pigs (
 <xref ref-type="supplementary-material" rid="FS2">Supplementary Figure S2</xref>). In contrast, there were no detectable antibodies to gE.
</p>
